October 31, 2025
Clozapine is a highly effective atypical antipsychotic, but it’s not without drawbacks (Table 1). Historically, patients, prescribers and pharmacies were required to enroll in the Clozapine REMS program due to the drug’s potential to cause agranulocytosis. The REMS program was officially eliminated on June 13th, 2025, though the FDA still recommends that prescribers monitor absolute […]
Read MoreOctober 21, 2025
Our “Together as One” series spotlights nurses, physicians, pharmacy staff and others who positively impact the lives of hospice patients and their families every day. Through the dedicated and compassionate work of these inspiring professionals, patients receive the high-quality care and attentive consideration they deserve. Together with innovative and responsive hospice partners, they create the […]
Read MoreAugust 19, 2025
Our hospice partners occasionally ask how to convert patients from one antiseizure medication (ASM) to another. These requests are usually driven by cost or formulary considerations, but other common reasons include lack of efficacy, intolerable adverse effects, and problematic drug-drug interactions. Ideally, formulary / cost shouldn’t be the sole basis for rotating to an alternate […]
Read MoreMay 8, 2025
Our “Together as One” series spotlights nurses, physicians, pharmacists and others who positively impact the lives of hospice patients and their families every day. Through the dedicated and compassionate work of these inspiring professionals, patients receive the high-quality care and attentive consideration they deserve. Together with innovative and responsive hospice partners, they create the network […]
Read MoreMay 7, 2025
Our “Together as One” series spotlights nurses, physicians, pharmacists and others who positively impact the lives of hospice patients and their families every day. Through the dedicated and compassionate work of these inspiring professionals, patients receive the high-quality care and attentive consideration they deserve. Together with innovative and responsive hospice partners, they create the network […]
Read MoreApril 18, 2025
Originally published on HospiceNews.com Views, read about Hope Hospice’s experience utilizing MyMetRx: For Hope Hospice, prescribing habits were… fine. Not bad. Not great. An affiliate of Chapters Health System, Hope Hospice, based in Fort Myers, Florida, was looking for ways to optimize their ordering habits — particularly for drugs that could be deprescribed or that […]
Read MoreApril 14, 2025
In light of the ongoing opioid crisis, there’s been a significant push to develop new medications for pain that have fewer side effects and lower risks of addiction and overdose. The highly anticipated approval of suzetrigine (trade name Journavx) in January 2025 marks the first time in over 20 years that a drug from a […]
Read MoreMarch 20, 2025
OnePoint Patient Care’s Vice President of Clinical Services Joe Solien, PharmD, BCPP, BCGP was named a 2024 Frontline Hero by Hospice News. According to Hospice News, a Frontline Honoree is: A dedicated, high-performing frontline worker who delivers exceptional experiences and outcomes A passionate worker who knows how to put their vision into action for the […]
Read MoreFebruary 3, 2025
Generally speaking, the use of vitamins at end of life is not beneficial. Still, hospice patients with age-related macular degeneration (AMD) might be reluctant to stop taking their eye vitamins out of fear of going blind during their final months of life. AMD is a degenerative disease that damages the macula (the central portion of […]
Read MoreJanuary 30, 2025
Experienced pharmacy provider now bringing expert dispensing and personalized support to PACE participants Morton Grove, IL – January 30, 2025 – OnePoint Patient Care, a leading provider of community based pharmacy services, is proud to announce the launch of OnePoint PACE, a new business line that will bring the company’s medication dispensing expertise and high […]
Read More